BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21145825)

  • 1. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.
    Selzner N; Selzner M; Jochum W; Amann-Vesti B; Graf R; Clavien PA
    J Hepatol; 2006 Apr; 44(4):694-701. PubMed ID: 16229921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2).
    El-Badry AM; Jang JH; Elsherbiny A; Contaldo C; Tian Y; Raptis DA; Laczko E; Moritz W; Graf R; Clavien PA
    J Hepatol; 2011 Dec; 55(6):1291-9. PubMed ID: 21703192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.
    El-Badry AM; Moritz W; Contaldo C; Tian Y; Graf R; Clavien PA
    Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemia-reperfusion injury in rat fatty liver: role of nutritional status.
    Caraceni P; Nardo B; Domenicali M; Turi P; Vici M; Simoncini M; De Maria N; Trevisani F; Van Thiel DH; Derenzini M; Cavallari A; Bernardi M
    Hepatology; 1999 Apr; 29(4):1139-46. PubMed ID: 10094958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.
    Marí M; Caballero F; Colell A; Morales A; Caballeria J; Fernandez A; Enrich C; Fernandez-Checa JC; García-Ruiz C
    Cell Metab; 2006 Sep; 4(3):185-98. PubMed ID: 16950136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
    Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2',7'-Dichlorofluorescein is not a probe for the detection of reactive oxygen and nitrogen species.
    Reiniers MJ; van Golen RF; van Gulik TM; Heger M
    J Hepatol; 2012 May; 56(5):1214-1216. PubMed ID: 22127279
    [No Abstract]   [Full Text] [Related]  

  • 11. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats.
    Marsman HA; Heger M; Kloek JJ; Nienhuis SL; ten Kate FJ; van Gulik TM
    Dig Liver Dis; 2011 Dec; 43(12):984-90. PubMed ID: 21840275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury.
    Caraceni P; Domenicali M; Vendemiale G; Grattagliano I; Pertosa A; Nardo B; Morselli-Labate AM; Trevisani F; Palasciano G; Altomare E; Bernardi M
    J Surg Res; 2005 Apr; 124(2):160-8. PubMed ID: 15820243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
    Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
    Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status.
    Domenicali M; Vendemiale G; Serviddio G; Grattagliano I; Pertosa AM; Nardo B; Principe A; Viola A; Trevisani F; Altomare E; Bernardi M; Caraceni P
    Dig Liver Dis; 2005 Sep; 37(9):689-97. PubMed ID: 15935746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
    Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
    Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.